Immunogenicity is not improved by increased antigen dose or booster dosing of seasonal influenza vaccine in a randomized trial of HIV infected adults.
about
Long-term follow-up in patients with HIV vaccinated with pandemic influenza A(H1N1)/09 AS03-adjuvanted split virion vaccine and seasonal trivalent influenza split virion vaccineImmunogenicity of Licensed Influenza A (H1N1) 2009 Monovalent Vaccines in HIV-Infected Children and Youth.Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccineUnadjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected adults.High-level immunogenicity is achieved vaccine with adjuvanted pandemic H1N1(2009) and improved with booster dosing in a randomized trial of HIV-infected adults.High proportions of regulatory B and T cells are associated with decreased cellular responses to pH1N1 influenza vaccine in HIV-infected children and youth (IMPAACT P1088)The cost-effectiveness and value of information of three influenza vaccination dosing strategies for individuals with human immunodeficiency virus.Delivery of subunit influenza vaccine to skin with microneedles improves immunogenicity and long-lived protectionVitamin D Levels, Natural H1N1 Infection and Response to H1N1 Vaccine among HIV-Infected IndividualsPhase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine versus standard-dose intramuscular vaccine in HIV-1-infected adults.Safety and immunogenicity of influenza vaccine among HIV-infected adults: Conventional vaccine vs. intradermal vaccineBooster and higher antigen doses of inactivated influenza vaccine in HIV-infected patients.Changing face of vaccination in immunocompromised hosts.Vaccination of HIV-infected pregnant women: implications for protection of their young infants.Serological response to trivalent inactivated influenza vaccine in HIV-infected adults in Singapore.British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015.Timing Matters - Influenza Vaccination to HIV-Infected PatientsSometimes, more is better.Vitamin D supplementation does not increase immunogenicity of seasonal influenza vaccine in HIV-infected adults.
P2860
Q30353329-5163D811-A398-44FA-A025-2D07D7443869Q30357158-DF0D4ACF-2F18-41F1-9BF4-3C36D9CCA077Q30373691-6599E45D-F516-4F28-A636-F411C69D297EQ30407911-7C7234B8-EEF4-4DE4-8E94-0AC7FF47A3B3Q30412595-0DBCB3F4-48D5-4EB3-846B-69856A80389CQ30426654-66245C71-FC80-4D9F-A61D-4D88C63B511FQ34097791-857DC433-23B8-4918-94A5-F8C5F683EAD1Q35885039-296DDD2E-08B8-44A7-A71C-28AB4C9E0A60Q36447199-5BC717EE-5CB3-4D26-9BC9-E5CDD0B3F899Q36552868-8E79BB99-A216-4856-9CF3-7BAE6C0A56CBQ37309289-D1609171-7DAA-43B6-8DFA-D7E8D35E0810Q38164661-45A1907C-BDA6-45F2-B0A2-FDCEBD8928BCQ38225998-EBB24A8F-1CCA-49D9-B543-E145D1E1608BQ40051928-85984725-1C5B-4E8B-8D47-7CA065EA772BQ40300395-39A08069-D491-4DDA-8F6F-20816399A4B6Q40560650-C75197E4-A6B6-4D0D-8E67-538A73ECB858Q40818149-9B4EACAA-620E-41B5-8038-76B82FA16CE8Q42788819-ABFC3A64-5392-42C2-A57D-C167C30CA549Q44420213-849CCF31-1823-4011-9E2D-64F37DD2618B
P2860
Immunogenicity is not improved by increased antigen dose or booster dosing of seasonal influenza vaccine in a randomized trial of HIV infected adults.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Immunogenicity is not improved ...... trial of HIV infected adults.
@ast
Immunogenicity is not improved ...... trial of HIV infected adults.
@en
type
label
Immunogenicity is not improved ...... trial of HIV infected adults.
@ast
Immunogenicity is not improved ...... trial of HIV infected adults.
@en
prefLabel
Immunogenicity is not improved ...... trial of HIV infected adults.
@ast
Immunogenicity is not improved ...... trial of HIV infected adults.
@en
P2093
P2860
P1433
P1476
Immunogenicity is not improved ...... trial of HIV infected adults.
@en
P2093
Anona Thorne
Brian Conway
CIHR Canadian HIV Trials Network Influenza Vaccine Research Group
Curtis Cooper
David Haase
Guy Boivin
Joel Singer
Marina Klein
Sharon Walmsley
Stephen Shafran
P2860
P304
P356
10.1371/JOURNAL.PONE.0017758
P407
P577
2011-03-25T00:00:00Z